Sensitron to Expand Into Northeast and Non-Hospital Healthcare Markets with Genadyne Biotechnologies
New York-Based Company Contributes Home Healthcare and Nursing Home Experience
SAN MATEO, CA (PRWEB) May 2, 2005
Sensitron, Inc., a wireless healthcare innovations company, announced that New York-based Genadyne Biotechnologies, Inc., a support surfaces and seating systems manufacturer, will both distribute Sensitron’s careTrends™ Wireless Bridge as well as represent Sensitron in the home healthcare, nursing home and assisted living facility markets in New York, Massachusetts, Rhode Island, New Jersey, New Hampshire, Connecticut, Pennsylvania and Florida.
“Genadyne Biotechnologies has a wealth of experience in the home healthcare, nursing home and assisted living facility markets and can extend, to the non-hospital care environments, the improved staff efficiencies, workflows and productivity that Sensitron’s careTrends is delivering to hospitals. We look forward to expanding our marketing reach into new markets and geographical regions,” said Rajiv Jaluria, CEO and Chairman of Sensitron. “We are very excited to bring this revolutionary and innovative technology to the Northeast and we are certain that it will help improve patient care through increased data accuracy and reduced transcription errors,” said Shahzad Pirzada, President of Genadyne.
Device-Agnostic System Fulfills Healthcare ProvidersÂ’ Demands
Sensitron’s careTrends enables a wide array of vital signs and other clinical data to be transmitted wirelessly, via secure encryption, to any existing server-based electronic patient record. Sensitron’s unique system works with monitors from different manufacturers, including legacy systems, and is an integrated open system—which sits well with the home healthcare, nursing home and assisted living facility markets. With Sensitron’s careTrends system, potential errors in data transmission are reduced by dating and timing all data—which creates an effective audit trail. The system directly links point-of-care medical devices with clinical information systems, thus reducing staff time, clinical risk and allowing medical staff to maintain a higher standard of clinical care.
The careTrends system supports numerous different applications for hospitals, clinics, nursing facilities and long-term care homes. The system also addresses healthcare providersÂ’ needs, including immediate access to information and reduction in paperwork. PatientsÂ’ data and trends can be presented intra-hospital, inter-hospital, at a clinicianÂ’s office, or via any web-based personal digital assistant (PDA) or telephone.
Scalable System Accommodates Multiple Locations Improving the Standard of Patient Care
The careTrends system uses a combination of wireless Bluetooth and 802.11b communications protocols for data transmission to a healthcare facilityÂ’s server. SensitronÂ’s enterprise software in the server collects the readings and records results according to parameters set by the clinician before presenting data to caregivers. The system is modular and can accommodate multiple locations with data communication customized per patient.
By combining vital signs data with other related clinical patient records, the clinician is armed with a complete view of the patientÂ’s status, thus enabling him or her to make a better assessment of the patientÂ’s overall health.
About Genadyne Biotechnologies, Inc. (http://www. genadyne. com (http://www. genadyne. com))
Genadyne Biotechnologies, Inc., based in Great Neck, NY, was founded in 1999 by Shahzad Pirzada, President. Genadyne manufactures UL-compliant specialty-wound care support surfaces (powered and non-powered) for the long-term care and home care markets in the northeastern United States. Genadyne also distributes its products internationally.
About Sensitron, Inc. (http://www. sensitron. net (http://www. sensitron. net))
Sensitron, Inc., based in San Mateo, Calif., is a wireless healthcare innovations company that has developed the careTrends Wireless Bridge system. The unique breakthrough system minimizes transcription errors and eliminates lag time between the reading, capture, documentation and dissemination of clinical data. This is accomplished by communicating vital signs and other data from wirelessly-enabled, legacy point-of-care medical devices at the bedside. Sensitron, founded in 1997, is a privately-held company, and is backed by and in partnership with NewMarket Technology, Inc. (OTCBB: NMKT).
CareTrends is a trademark of Sensitron, Inc.
###
